INTRODUCTION
============

Type 2 diabetes mellitus (DM) is a group of disorders characterized by hyperglycemia and associated micro vascular (retinal, renal, possibly neuropathic), macro vascular (coronary, peripheral vascular), and neuropathic (autonomic, peripheral) complications. Unlike Type 1 diabetics, patients are not absolutely dependent upon insulin for life, even though many of these patients are ultimately treated with insulin.^[@B1]^

Prevalence of type 2 diabetes and diabetic Retinopathy in Pakistan is 10% and 27% respectively.^[@B2],[@B3]^ A spectrum of retinal changes accompanying long-standing diabetes may advance to cause the abnormal retinal neovascularization, which may lead to severe visual loss and even blindness. Diabetic retinopathy is a leading cause of visual impairment among diabetic patients.

There are many reports from various countries about incidence and prevalence of diabetic retinopathy and the risk factors associated with this condition. Limited studies are available on risk factors associated with diabetic retinopathy in Pakistan. Stratton et al reported that older age, male gender, hyperglycemia (persistently raised HbA1c), hypertension and smoking were significantly associated with the incidence and progression of retinopathy in type 2 diabetic patients.^[@B4]^ Chatziralli IP et al found duration of diabetes, hypertension, poor glycemic control and male gender as strong independent risk factors of retinopathy and they reported that the age was a confounding factor.^[@B5]^ A study on large number of diabetics having retinopathy (n=7577) from Asia found duration of disease, elevated blood glucose levels and high blood pressure as independent risk factors.^[@B6]^

In the blood stream are the red blood cells, which contain a molecule called hemoglobin. Glucose sticks to the hemoglobin to make a 'glycosylated hemoglobin' molecule, known as HbA1c. More the glucose and more HbA1C will be present in the blood. Red cells remain alive for 8-12 weeks before they are replaced. By measuring the HbA1c, how high blood glucose has been on average over the last 8-12 weeks can be assessed. A normal non-diabetic HbA1C is 3.5-5.5%. The HbA1c test is currently one of the best ways to check the control of diabetes. Persistent elevation in serum glucose (HbA~1c~) increases the risk for the long-term vascular complications of diabetes such as retinopathy.^[@B7],[@B8]^

High levels of hemoglobin A1c (HbA1c) for long duration are important risk factor for progression to high risk proliferative diabetic retinopathy and decreased visual acuity. Intensive glycemic control for long duration (HbA1c levels normal or near normal) reduces the risk of retinopathy significantly. Intensive therapy is most effective when initiated early in the course of the diabetes, demonstrating a beneficial effect over the course and progression of retinopathy.^[@B9],[@B10]^

Our objective was to find out various risk factors associated with retinopathy in type 2 diabetes mellitus.

***Operational Definitions:***

***Diabetic retinopathy*** A diagnosis of diabetic retinopathy will be established if the subject has a minimum of one micro aneurysm in any field, or showing hemorrhages (dot & blot, or flame shaped), or maculopathy (with or without clinically significant edema).

***High glycosylated hemoglobin (HbA1c)*** Value of glycosylated hemoglobin more than 7% will be taken as high.

***Poor:*** A person who earn less than 2\$ per day.

METHODOLOGY
===========

Patients of type 2 diabetes mellitus (DM) of both genders irrespective of duration of diabetes, more than 30 years of age attending Bahawal Victoria Hospital, Bahawalpur were included in this cross sectional descriptive study. It was conducted at Department of Pathology, Department of Ophthalmology Bahawal Victoria Hospital/ Quaid-e-Azam Medical College Bahawalpur between July 2011 to June 2012.Patients of type I DM, Known cases of retinopathy which may be due to causes other than DM and value of HbA1c less than 7% were excluded.

***Sample size:*** Sample size was 299, rounding off the nearest whole number 300. The prevalence of retinopathy in type2 DM was 27%. Purposive Sampling technique was used for this study. The study was approved by the local ethical committee. After taking written and verbal consent from the patients, a structured proforma containing demographic features, duration of DM, oral or insulin therapy was filled. Blood samples were collected for analysis of HbA1c, serum total cholesterol and LDL cholesterol. HbA1c was measured by Boronate affinity chromatography (Clover A1c). Total and LDL cholesterol were measured by automated chemistry analyzer. A detailed fundus examination was performed by slit lamp bio microscopy.

***Data analysis:*** Data was analyzed using SPSS version 17. The results were evaluated using frequencies, proportions and group means. The frequencies and percentages were calculated for all the qualitative data including gender, age group, and diabetic retinopathy.

RESULTS
=======

Mean age of the patients was 49.04 ± 0.69 years. Females were slightly predominant (n=174, 56.1%) as compared to males (M:F ratio 3:4). All patients were type 2 diabetics with average duration of disease of 7.17 ± 0.38 years. Diabetic retinopathy was diagnosed in about 1/4^th^ patients (n=74, 23.9%). Mean HbA1c was 8.71 ± 0.08 percent. A majority of patients was literate (n=198, 63.9%) as compared to illiterate (n=112, 36.1%), similarly 187 patients (60.3%) had good socioeconomic status as compared to poor patients (n=123, 39.7%). It was found that patients (n=105, 33.9%) were counseled by the treating doctor about compliance to medication and complications of diabetes mellitus if poorly controlled, as compared to 205 (66.1%) patients who were just prescribed treatment without counseling. Family cooperation was noted in 227 (73.2%) patients. History of Hakeem medication was found in 119 (38.4%) patients. As shown in [Table-I](#T1){ref-type="table"}, there was no statistical difference of mean HbA1c among the patients who had diabetic retinopathy or not (p = 0.080).

###### 

Comparison of HbA1c in diabetic patients having retinopathy

            *Retinopathy*   *N*      *Mean*   *Std. Deviation*   *Std. Error Mean*
  --------- --------------- -------- -------- ------------------ -------------------
  *HbA1c*   Yes             74       8.154%   1.1169             .1298
  No        236             8.884%   1.4488   .0943              

Mean duration of diabetes mellitus who had developed retinopathy was 16.05 ± 0.903 years as compared to 4.39 ± 0.197 years who had not developed retinopathy yet. Independent Samples t Test was applied and a statistically significant difference (0.0001) was calculated as shown in [Table-II](#T2){ref-type="table"}.

###### 

Association of duration of diabetes with development of retinopathy

                     *N*   *Mean duration in years*   *Std. Deviation*   *Std. Error Mean*
  ------------------ ----- -------------------------- ------------------ -------------------
  *Retinopathy*      74    16.05                      7.767              .903
  *No Retinopathy*   236   4.39                       3.029              .197

.Although there was slight female preponderance among type 2 diabetics however, males were found to have higher frequency of retinopathy (n=41/136, 30.15%) as compared to females (n=33/174, 18.96%). Similarly, high serum total cholesterol, high serum LDL-cholesterol, presence of albuminuria and insulin therapy were found to have significant associations with the development of diabetic retinopathy as shown in [Table-III](#T3){ref-type="table"}. Chi square was applied which revealed significant difference (p = 0.023) between the two genders.

###### 

Association of various risk factors with diabetic retinopathy

  -----------------------------------------------------------------------
  *Risk factors*                     *Retinopathy*   *p value*   
  ---------------------------------- --------------- ----------- --------
  GenderMaleFemale                   41/136\         30.15%\     0.023
                                     33/174          18.96%      

  Age≤49 years\>49 years             13/164\         7.93%\      0.0001
                                     61/146          41.78%      

  Total cholesterolNormalHigh        19/119\         15.97%\     0.010
                                     55/191          28.79%      

  LDL cholesterolNormalHigh          33/198\         16.67%\     0.0001
                                     41/112          36.61%      

  AlbuminuriaAbsentPresent           14/193\         7.25%\      0.0001
                                     60/117          51.28%      

  TherapyInsulinOral hypoglycemics   49/74\          66.22%\     0.001
                                     25/234          10.68%      
  -----------------------------------------------------------------------

DISCUSSION
==========

Diabetes mellitus is a global problem and diabetic retinopathy is a common complication of this systemic disorder with its overall global prevalence of 34.6% (range = 17.99% -- 51.2%).^[@B11]^ However, the studies from within Pakistan show the prevalence of diabetic retinopathy ranging from 9.0% to 43.0%.^[@B12]-[@B15]^ Insulin treatment, duration of diabetes, age at examination, HbA1c, systolic blood pressure, cholesterol, triglyceride and microalbumin were found to be significantly related to the development and the progression of retinopathy among type 2 diabetics from Kuwait by AlKharji et al.^[@B16]^ However, a recent study by Chitrazalli and colleague documented that effect of age is a confounding factor but years since DM diagnosis, hypertension, serial high HbA1c levels and male sex were independent risk factors for the development of diabetic retinopathy.

In our study there is no significant association of retinopathy with single high HbA1c level among patients of type 2 diabetes. It is common observation that most of the patients of type 2 diabetes have high HbA1c levels at the time of diagnosis of the disease but they have no retinopathy at that time. There are many studies conducted in various countries over the period of last decade or so which provide fair evidence of association of persistently high HbA1c with the development of various grades of retinopathy in type 2 diabetic patients.^[@B17]-[@B19]^

In our patients, the overall frequency of retinopathy was 23.9% whereas a study from Karachi involving large number of diabetic patients reported similar frequency of retinopathy (27.4%).^[@B20]^ Another study conducted recently, showed higher frequency (34.5%),^[@B21]^ however this difference may be attributed to patient selection in that study and/or other demographic variables.

Our study showed that the retinopathy was found in 74 patients whose average duration of type 2 diabetes was 16.05±0.90 years as compared to those who had no retinopathy. The latter group of patients had 236 patients with mean duration of disease of 4.39±0.20 years. Thus a strong correlation was found between the retinopathy and duration of diabetes. Many other studies have also identified the duration of diabetes as the major risk factor of the development of diabetic retinopathy.^[@B22]^ Shaukat et al also showed positive correlation between the duration of diabetes with the incidence of retinopathy as in current study.^[@B23]^

CONCLUSIONS
===========

Diabetic retinopathy was found in 23.9% of type 2 diabetics which was significantly associated with male gender, duration of diabetes, older age, high cholesterol, high LDL, albuminuria and insulin therapy. No association of high HbA1c levels for short duration (months not years) was found with diabetic retinopathy. Persistently raised HbA1c level may be associated with diabetic retinopathy.
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